A Synergistically Enhanced Cerium-Based Nanozyme: Multi-Effect Strategy for Diabetic Wound Healing
BIO Integration · 2026 · 7 (1)
DOI: 10.15212/bioi-2026-0136 ↗Abstract
Abstract Objective: Diabetic wound healing is frequently impaired by excessive oxidative stress, persistent inflammation, and insufficient tissue regeneration. The aim of this study was to develop a multifunctional cerium-based nanozyme capable of regulating the oxidative and inflammatory microenvironments to promote diabetic wound repair. Methods: A tannic acid–functionalized cerium-based nanocomposite (Ce@BSA-TA) was constructed via bovine serum albumin (BSA)-mediated biomineralization followed by tannic acid (TA) modification. The physicochemical properties and enzyme-mimetic activity of Ce@BSA-TA were characterized, and its ability to scavenge reactive oxygen species (ROS) was evaluated. Cytoprotective and pro-migratory effects were investigated in vitro under high-glucose–associated oxidative stress. A diabetic mouse model with full-thickness skin wounds was used to evaluate wound healing, inflammatory regulation, angiogenesis, and collagen deposition. Results: Benefiting from the Ce 3+ /Ce 4+ redox cycle, Ce@BSA-TA exhibited superoxide dismutase (SOD)- and catalase (CAT)-mimetic activities and effectively scavenged superoxide anions (O 2 •− ) and hydrogen peroxide (H 2 O 2 ). Ce@BSA-TA alleviated intracellular oxidative stress, protected cells from oxidative damage, and promoted fibroblast migration in vitro . In diabetic wounds, Ce@BSA-TA reduced oxidative stress and pro-inflammatory cytokine expression, promoted macrophage polarization toward the M2 phenotype, and enhanced angiogenesis and collagen deposition, which collectively accelerated wound closure. Conclusion: Ce@BSA-TA integrates ROS scavenging and immunomodulatory activities to improve the hostile microenvironment of diabetic wounds and promote tissue repair. Our study findings support the potential of multifunctional cerium-based nanozymes as a therapeutic strategy for the management of chronic diabetic wounds.
EUVIMED